A Mobile Phone-based Intervention on Dementia Patients' Caregivers in Vietnam

December 18, 2023 updated by: Nguyen Tran To Tran, University of Medicine and Pharmacy at Ho Chi Minh City

Evaluating the Feasibility of a Mobile Phone-based Intervention (Zalo App) on Depression, Anxiety, and Stress of Family Caregivers of People With Dementia.

Background: The growing number of older people with dementia increases demand on informal caregivers who lack information and skills, leading to a high psychological burden in care provision. The proposed smartphone app-based intervention will provide a convenient and feasible solution for reducing depression, stress, and anxiety among dementia carers in Vietnam. This study aims to: (1) understanding the information and skills required by informal carers to populate the content of the intervention and (2) test the clinical feasibility of the intervention and feasibility of a fully- power randomized controlled trial.

Methods: The setting of this study is the geriatrics department in Gia Dinh People's hospital in Ho Chi Minh City. The eligible participants are the informal caregivers of patients with dementia living in the community, who use smartphones. Phase 1 will involve 20 interviews, conducted with 20 dementia carers to determine what information and skills they need most. These findings will be used to design the content of the intervention, which will comprise 8 weekly, online, psycho-educational, group sessions hosted on the Zalo app. Phase 2: using a pilot randomized control trial design, 60 participants will be assigned to the intervention or control group by the block randomization method with a ratio of 1:1. The participants will complete questionnaires at baseline, post-intervention and 3 month post-intervention. Outcome measures include DASS21 (Depression, anxiety and stress 21), dementia understanding, perceived social support, and caregiver's perceived burden. The primary outcome is the feasibility of the intervention and a future fully-power randomized controlled trial including acceptability and perceived effectiveness of the intervention and the rate of recruitment, retention, and completion of assessments.

Study Overview

Detailed Description

The study has two phases: the co-design of the content of the intervention (phase 1) and the randomized controlled trial phase (phase 2). The setting and the participants' eligibility criteria are the same for the two phases.

Phase 1 Design: a qualitative study will be conducted on 20 caregivers of patients with dementia to identify what information they most require.

Method: 20 face-to-face interviews will be held and guided by a trained geriatrician, in a private room in the geriatrics department. The open-ended questions are used, including "what difficulties are the participant facing in taking care of the patient with dementia?", "what information do the participant need most?". Each participant will be free to share thoughts. The interviews will be audio-recorded and fully transcribed.

Data analysis: The investigator will use inductive thematic content analysis. The eight most common issues in which the carers need providing information will be determined to shape for the intervention in phase 2.

Phase 2 Study design A parallel-group randomized controlled pilot trial will be used with equal randomization of 1:1 to test the feasibility and the acceptability of the smartphone app-based intervention. Sixty dementia carers, who meet the eligible criteria and are provided written informed consent, will be enrolled in the study and will be allocated to the intervention or usual care group.

Randomization The eligible participants will be assigned to the intervention or control group by an independent statistician, using the block randomization method (blocks of 4).

Intervention The participants in the intervention group will be added to a chat room in the Zalo app, created and managed by one investigator, which is named The Dementia Caregiver Support group. Weekly, the investigator will post one of the eight topics identified in Phase 1. Before posting the information, the investigator will ask the participants what topic they would like to read and discuss the week after by voting the answer. The posted information will be based on evidence-based resources and consulted by geriatricians, the neurologist, and the psychologist who specialize in dementia. Immediately after posting the topic, one investigator will call the participants to ensure the participants read and understand the post. The chat group monitor will also collect the questions or comments from the carers who are encouraged to share feelings or experiences with relevant questions. Then the investigator will post the answers after consulting with the experts.

Usual care: The participants in the control group will be introduced to the website Alzheimer.org to search for eligible information Procedure The characteristics of the participants (age, gender, educational level, relationship to the care recipient, time of care, etc.) and other assessments will be collected by an independent investigator, who will be blinded through the study.

Measures The participants will perform the Depression, anxiety and stress scale 21 (DASS21) questionnaire via phone call interviews. DASS21 scale contains 21 items, evaluating 3 subscales including depression, anxiety, and stress states over the past week. Higher scores indicate more severity of emotional states. Dementia understanding of the participants will be evaluated at baseline and post-intervention by a questionnaire, originating from the Northern Ireland Life and Time Survey, which was translated into Vietnamese. This questionnaire contains 7 items, for example, "dementia is a normal part of aging" or "dementia can be cured". The response options will be completed with yes/no choices. Four or fewer correct answers will be coded as low understanding, five correct answers medium understanding, and six or more answers as high understanding.

Perceived social support will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), comprising 12 self-report items assessing the perceived support from family, friends, or significant others (eg, "There is a person who is around me when I am in need). Each item is scored from 1 (very strongly disagree) to 7 (very strongly agree), based on a 7-point Likert scale. Higher scores indicate higher degrees of perceived social support. This scale will be translated and adapted into Vietnamese.

The caregiver's perceived burden will be evaluated usingthe Zarit 4-item burden interview. Each item is scored from 0 to 4, and higher scores indicate higher levels of burden.

Outcome measurements will be assessed face-to-face at baseline and via phone calls at immediate post-intervention and 3-month follow-up post-intervention.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ho Chi Minh City, Vietnam, 70000
        • Recruiting
        • Gia Dinh People's Hospital
        • Contact:
        • Contact:
        • Principal Investigator:
          • The HN Than, PhD
        • Sub-Investigator:
          • Tran TT Nguyen, MSc
        • Sub-Investigator:
          • Tuan C Nguyen, MSc
        • Sub-Investigator:
          • Phong T Vo, MD
        • Sub-Investigator:
          • Lan TD Vu, MD
        • Sub-Investigator:
          • Khoa T Truong
      • Ho Chi Minh City, Vietnam, 70000
        • Recruiting
        • University of Medicine and Pharmacy at Ho Chi Minh City
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Tran TT Nguyen, MSc
        • Sub-Investigator:
          • Tuan C Nguyen, MSc
        • Sub-Investigator:
          • Phong T Vo, MD
        • Sub-Investigator:
          • Lan TD Vu, MD
        • Sub-Investigator:
          • Khoa T Truong
        • Principal Investigator:
          • The NH Than, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being the primary caregivers of patients with dementia for at least the past 6 months and will continue to be for the next 6 months of the intervention. Dementia patients are those who have been diagnosed with dementia for at least 6 months and are living in the community.
  • Being able to read and understand Vietnamese (at least primary education), and willing to participate in the study.
  • Having a smartphone that has the Zalo app or willing to have this Zalo app be installed (there will be short training of using Zalo for new users)
  • Aged ≥ 18 years

Exclusion Criteria:

  • Having any acute diseases or cognitive impairment (screening by Mini-Cog),
  • Having vision or hearing impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Informational support group
The participants in the intervention group will be added to a chat group in the Zalo app, created and managed by one investigator, which is named The Dementia Caregiver Support group. Weekly, the investigator will post one of the topics identified in Phase 1. Before posting the information, the investigator will ask the participants what topic they would like to read and discuss the week after by voting the answer. The posted information will be based on evidence-based resources and consulted by geriatricians, the neurologist, and the psychologist who specialize in dementia. Immediately after posting the topic, one investigator will call the participants to ensure they read and understand the post. The chat group monitor will also collect the questions or comments from the carers who are encouraged to share their feelings or experiences with relevant questions. Then the monitor will post the answers after consulting with the experts.
The intervention will be administered to the participants via a smartphone app (Zalo app). Weekly, the investigator will post one of the eight topics identified in Phase 1 in the chat room. After posting the topic, one investigator will call the participants to ensure they read and understand the contents.
Active Comparator: Controlled group
The participants will receive usual care, introduced to the website Alzheimer.org to search for eligible information.
Caregivers will be introduce to the website www.alzheimer.org to search for eligible information

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The most common topics related to dementia patient care skills
Time Frame: 4 months
The investigators will address these issues by in-deep interviews in phase 1. The most common topics the participants need providing will be listed
4 months
The rate of recruitment, retention and completeness of outcome measurements
Time Frame: 9 months

The rate of recruitment will be identified by the percentage of participants agree to participate in the study.

The rate of retention will be identified by the percentage of participants stay in the study. The rate of completeness the outcome measurements is the percentage of participants agree to answer the questionnaires during the study. The rate of recruitment, the rate of participant retention and the rate of completeness of outcome measurements will be reported in percentages.

9 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression, anxiety and stress levels of the caregivers
Time Frame: 9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
The participants will be evaluated by the Depression, anxiety and stress 21 scale. The score of each subscale will range from 0 to 42. The minimum score is 0 and the maximum score is 126. The higher scores indicates worse outcome
9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
Dementia understanding of the caregivers about dementia
Time Frame: 9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
The participant will be evaluated by the questionnaire originating from Northern Ireland Life and Time Survey questionnaire which includes 7 items. The score will range from 0 to 7. A higher score indicates a better outcome.
9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
Perceived social support of the caregivers
Time Frame: 9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
The participant will be evaluated by the Multidimensional perceived social support scale (MSPSS) which includes 12 items. Each item is scored from 1 (very strongly disagree) to 7 (very strongly agree), based on a 7-point Likert scale. The minimum score is 12 and the maximum score is 84. Higher scores indicate higher degrees of perceived social support
9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
Perceived burden
Time Frame: 9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention
The participants will be evaluated by the Zarit 4-item burden interview, including 4 items. Each item is scored from 1 to 4. A Higher score indicates a higher feeling of burden.
9 months. It will be evaluated at baseline, post-intervention and 3-month post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2023

Primary Completion (Estimated)

August 30, 2024

Study Completion (Estimated)

December 30, 2024

Study Registration Dates

First Submitted

June 20, 2021

First Submitted That Met QC Criteria

July 1, 2021

First Posted (Actual)

July 12, 2021

Study Record Updates

Last Update Posted (Actual)

December 19, 2023

Last Update Submitted That Met QC Criteria

December 18, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Share the results of the study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Information including knowledge and skills related to dementia patient care

3
Subscribe